AUG 20, 2026 · PHASE 2 TRIAL
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
ClinicalTrials.gov
This is a Phase 1/2A open-label, non-randomized safety and tolerability study of an investigational agent; no results are reported in this registry record.
Reported
Planned enrollment362
Study phasePhase 1/2A
Primary outcome measure 1Number of participants with dose limiting t…